Home › NDC Lookup › RxCUI directory › RxCUI 860654

Epinastine hydrochloride 0.5 MG/ML Ophthalmic Solution — RxCUI 860654

RxNorm drug concept · Semantic clinical drug
RxCUI 860654 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI860654
Official nameEpinastine hydrochloride 0.5 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asepinastine hydrochloride 0.05 % Ophthalmic Solution; epinastine HCl 0.05 % Ophthalmic Solution; epinastine hydrochloride 0.05 % (as epinastine 0.044 % ) Ophthalmic Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)4,100 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Epinastine Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's focused on your eye symptoms, not your overall allergies. Epinastine blocks histamine — the chemical your immune system releases when you encounter an allergen like pollen — r...
  • What exactly does this eye drop do — is it treating my allergies or just the symptoms?
  • Every day is best. This medication is designed to prevent itching, not just relieve it after it starts. You should use one drop in each eye twice a day throughout your allergy seas...
  • Do I need to use it every day, or only when my eyes are really itchy?
📖 Read our full Epinastine Ophthalmic guide →

🕸️ Concept Web — How Epinastine hydrochloride 0.5 MG/ML Ophthalmic So... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Epinastine hydrochloride 0.5 MG/ML Ophthalmic Solution RxCUI 860654

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Epinastine 39684
    • Epinastine hydrochloride 236961
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Epinastine Ophthalmic Solution 402322
    • Epinastine hydrochloride Ophthalmic Solution 2647836
    • Epinastine Ophthalmic Product 1161905
    • Epinastine hydrochloride Ophthalmic Product 2659593
    • Ophthalmic Solution 7670
    • Ophthalmic Product 1151135
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Epinastine hydrochloride 0.5 MG/ML 860653

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Epinastine hydrochloride 0.5 MG/ML SCDC · 860653
  • Epinastine Ophthalmic Solution SCDF · 402322
  • Epinastine hydrochloride Ophthalmic Solution SCDFP · 2647836
  • Epinastine Ophthalmic Product SCDG · 1161905
  • Epinastine hydrochloride Ophthalmic Product SCDGP · 2659593

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 860654 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70069-0008-01 1 BOTTLE in 1 CARTON (70069-008-01) / 5 mL in 1 BOTTLE EPINASTINE HYDROCHLORIDE Somerset Therapeutics, LLC 2016-09-14
Observed labelers: Somerset Therapeutics, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$15.1838
Range $15.1838–$15.1838 · middle 50% $15.1838–$15.1838 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.